Combining glycoprotein blockers with fibrinolysis: a bold stroke?

被引:3
作者
Verheugt, FWA [1 ]
机构
[1] Univ Nijmegen, Med Ctr St Radboud, Dept Cardiol 540, Ctr Heart, Nijmegen, Netherlands
关键词
D O I
10.1016/j.ehj.2003.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1801 / 1803
页数:3
相关论文
共 12 条
[1]   Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial [J].
Antman, EM ;
Giugliano, RP ;
Gibson, CM ;
McCabe, CH ;
Coussement, P ;
Kleiman, NS ;
Vahanian, A ;
Adgey, AAJ ;
Menown, I ;
Rupprecht, HJ ;
Van der Wieken, R ;
Ducas, J ;
Scherer, J ;
Anderson, K ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 1999, 99 (21) :2720-2732
[2]   Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction - Results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial [J].
Antman, EM ;
Louwerenburg, HW ;
Baars, HF ;
Wesdorp, JCL ;
Hamer, B ;
Bassand, JP ;
Bigonzi, F ;
Pisapia, G ;
Gibson, CM ;
Heidbuchel, H ;
Braunwald, E ;
Van de Werf, F .
CIRCULATION, 2002, 105 (14) :1642-1649
[3]   Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials [J].
Boersma, E ;
Harrington, RA ;
Moliterno, DJ ;
White, H ;
Théroux, P ;
Van de Werf, F ;
de Torbal, A ;
Armstrong, PW ;
Wallentin, LC ;
Wilcox, RG ;
Simes, J ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
LANCET, 2002, 359 (9302) :189-198
[4]   Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction - The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial [J].
Brener, SJ ;
Zeymer, U ;
Adgey, AAJ ;
Vrobel, TR ;
Ellis, SG ;
Neuhaus, KL ;
Juran, N ;
Ivanc, TB ;
Ohman, EM ;
Strony, J ;
Kitt, M ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (03) :377-386
[5]   Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction - Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) phase II angiographic trial [J].
Giugliano, RP ;
Roe, MT ;
Harrington, RA ;
Gibson, M ;
Zeymer, U ;
Van de Werf, F ;
Baran, KW ;
Hobbach, HP ;
Woodlief, LH ;
Hannan, KL ;
Greenberg, S ;
Miller, J ;
Kitt, MM ;
Strony, J ;
McCabe, CH ;
Braunwald, E ;
Califf, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) :1251-1260
[6]   Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction - GUSTO V randomized trial [J].
Lincoff, AM ;
Califf, RM ;
Van de Werf, F ;
Willerson, JT ;
White, HD ;
Armstrong, PW ;
Guetta, V ;
Gibler, WB ;
Hochman, JS ;
Bode, C ;
Vahanian, A ;
Steg, PG ;
Ardissino, D ;
Savonitto, S ;
Bar, F ;
Sadowski, Z ;
Betriu, A ;
Booth, JE ;
Wolski, K ;
Waller, M ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (17) :2130-2135
[7]   Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction - Dichotomous response as a function of age in the GUSTO V trial [J].
Savonitto, S ;
Armstrong, PW ;
Lincoff, AM ;
Jia, G ;
Sila, CA ;
Booth, J ;
Terrosu, P ;
Cavallini, C ;
White, HD ;
Ardissino, D ;
Califf, RM ;
Topol, EJ .
EUROPEAN HEART JOURNAL, 2003, 24 (20) :1807-1814
[8]  
Topol EJ, 2000, CIRCULATION, V101, P2788
[9]  
Topol EJ, 2001, LANCET, V357, P1905
[10]  
Van de Werf F, 2001, LANCET, V358, P605